[title missed]

Corresponding author: Ye Qi-dong, yeqidong@hotmail.com

DOI: 10.12201/bmr.202508.00027

•  

  Abstract: [abstract missed]

  Key words: ; ; ; 

  Submit time: 11 August 2025

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• 马亚鑫, ZHU Xiaowei, Li Shuqiong, Li Yunxiang, Sun Yonghong. MA Yaxin1, LI Shuqiong1, LI Yunxiang1, SUN Yonghong2▲. 2025. doi: 10.12201/bmr.202504.00073

  Lu jianliang, Feng yuan, Lu yanling. Analysis of clinical characteristics of severe mycoplasma pneumoniae pneumonia in children. 2025. doi: 10.12201/bmr.202505.00038

  ZHANG Xiao-Hua, YANG Yi-Tong. Progress of community-acquired respiratory distress syndrome toxins in Mycoplasma pneumoniae infection in children. 2025. doi: 10.12201/bmr.202506.00057

  changyanmei, yulijuan, 孟淑萍. The value of Mycoplasma pneumoniae RNA detection in the diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children. 2025. doi: 10.12201/bmr.202506.00025

  GENG Gang, LI Shaojun. Mycoplasma pneumoniae encephalitis in children: a case report and literature review. 2024. doi: 10.12201/bmr.202408.00042

  tangdongjing, wumeihui. Analysis of risk factors of bronchopneumonia and lobar pneumonia caused by mycoplasma pneumoniae. 2025. doi: 10.12201/bmr.202507.00035

  YE Hongzhou, YUAN Chen. Risk factors of severe pneumonia in children with macrolide-resistant Mycoplasma pneumoniae pneumonia and the construction of prediction model. 2024. doi: 10.12201/bmr.202409.00021

  shen tengteng, xu huiqing, xu yuebo, zheng jishan. Efficacy analysis of doxycycline in the treatment of Mycoplasma Pneumoniae Pneumonia in children under 8 years old. 2025. doi: 10.12201/bmr.202509.00001

  Li Feifan, Zhang shuitang. Impact of Mixed Infections and Antibiotic Resistance Genes on Clinical Features in Children with Mycoplasma pneumoniae Pneumonia. 2024. doi: 10.12201/bmr.202412.00025

  Wu Xiayang. Evaluation of the effectiveness and safety of generic and original azithromycin for the treatment of pediatric mycoplasma pneumonia. 2025. doi: 10.12201/bmr.202501.00071

• ID	Submit time	Number	Download
  1	2025-05-24	10.12201/bmr.202508.00027V1	Download

• Public  Anonymous  To author only Submit Comments